- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biofrontera Inc (BFRI)
The Biofrontera share price today is 0.8630, view NASDAQ BFRI stock exchange data. Track the latest Biofrontera share price with real-time updates on BFRI stock performance including market cap, day range, 52-week range and dividend yield. Access BFRI charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8504
0.9000
52 wk Range
0.5547
1.1900
BFRI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.85040.9000
52 wk Range
0.55471.1900
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BFRI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
5.8750
Upside
+580.76%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- Form 8K Biofrontera Inc For: 19 March
- Investing.com
- Form 8K Biofrontera Inc For: 10 March
- Investing.com
- Form 8K Biofrontera Inc For: 14 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 5.8750
(+580.76% Upside)
Biofrontera Inc Earnings Call Summary for Q1/2026
- Q1 2026 revenue rose 17% YoY to $10.1M; gross margin expanded to 80% from 62%, driven by strategic transaction with Biofrontera AG.
- Net loss improved to $4.8M ($0.41/share) vs $4.2M ($0.47/share) in Q1 2025; operating expenses increased 10% due to higher SG&A costs.
- Stock fell 2.9% in premarket despite 68% YTD gain; company faces going concern qualification due to potential liquidity challenges.
- FY2026 revenue guidance set at $46.76M; expects Q4 2026 profitability with $0.21 EPS after losses in Q2-Q3; FY2027 revenue forecast at $54.7M.
- FDA approval for Ameluz superficial basal cell carcinoma indication expected by Sept 28, 2026; potential tariff risks on European imports cited.
Last Updated: 14-05-2026, 09:14 pm
Read Full TranscriptEarnings
Latest Release
14-05-2026
EPS / Forecast
-0.41 / -0.06
Revenue / Forecast
10.08M / --
Compare BFRI to Peers and Sector
Metrics to compare | BFRI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBFRIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.0x | −3.4x | −0.5x | |
PEG Ratio | −0.03 | −0.05 | 0.00 | |
Price/Book | 1.8x | 1.4x | 2.6x | |
Price / LTM Sales | 0.2x | 2.1x | 3.0x | |
Upside (Analyst Target) | - | 112.3% | 58.6% | |
Fair Value Upside | Unlock | 36.9% | 10.2% | Unlock |
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Biofrontera (BFRI) Share Price Today?
The Biofrontera share price today is 0.8630.
What is the current Biofrontera (BFRI) share price and day range?
As of 10-06-2026, the Biofrontera share price is 0.8630, with a previous close of 0.8800. The share price has ranged from 0.8504 to 0.9000 today, while the 52-week range spans from 0.5547 to 1.1900.
What Is the Biofrontera Market Cap?
As of today, Biofrontera market cap is 10.5700M.
What Is the Biofrontera (BFRI) Share Price Target?
The average 12-month share price target for Biofrontera is 5.8750, with a high estimate of 9 and a low estimate of 2.75. 2 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +580.76% Upside potential.
What Is Biofrontera's Earnings Per Share (TTM)?
The Biofrontera EPS (TTM) is -1.0194.
When Is the Next Biofrontera Earnings Date?
Biofrontera will release its next earnings report on 07-08-2026.
From a Technical Analysis Perspective, Is BFRI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Biofrontera Trade On?
Biofrontera is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Biofrontera?
The stock symbol for Biofrontera is "BFRI."
How Many Times Has Biofrontera Stock Split?
Biofrontera has split 1 times.
How Many Employees Does Biofrontera Have?
Biofrontera has 89 employees.
What Is the BFRI Premarket Price?
BFRI's last pre-market stock price is 0.8797. The pre-market share volume is 2,670.0000, and the stock has changed by -0.0003, or -0.0300%.
What Is the BFRI After Hours Price?
BFRI's last after hours stock price is 0.8403, the stock has changed by -0.0227, or -2.6300%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.